---
title: Characterization of the adaptive immune response in a mouse model for HPV-positive
  head and neck squamous cell carcinoma with implications to human disease
date: '2025-01-03'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39751916/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250103170653&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: Head and neck squamous cell carcinoma (HNSCC) is the seventh most common
  cancer worldwide with a poor prognosis for survival. Risk factors include alcohol
  and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor
  immune responses immunotherapeutic approaches are approved for recurrent metastatic
  disease but only approx. 20% of patients respond to checkpoint blockade of the PD-1/PD-L1
  axis. Therefore, preclinical research is needed to better understand molecular ...
disable_comments: true
---
Head and neck squamous cell carcinoma (HNSCC) is the seventh most common cancer worldwide with a poor prognosis for survival. Risk factors include alcohol and tobacco abuse and infection with human papilloma virus (HPV). To enhance anti-tumor immune responses immunotherapeutic approaches are approved for recurrent metastatic disease but only approx. 20% of patients respond to checkpoint blockade of the PD-1/PD-L1 axis. Therefore, preclinical research is needed to better understand molecular ...